BTAI Stock Craters As Fraud Investigation Hammers Its ‘Huge Win’ In Alzheimer’s Study – Investor’s Business Daily

by

  1. BTAI Stock Craters As Fraud Investigation Hammers Its ‘Huge Win’ In Alzheimer’s Study Investor’s Business Daily
  2. BioXcel cites issues at Alzheimer’s drug trial site, shares plunge AOL
  3. BioXcel Therapeutics Announces Positive Topline Results From TRANQUILITY II Phase 3 Trial of BXCL501 for Acute Treatment of Alzheimer’s Disease-Related Agitation GlobeNewswire
  4. BioXcel Therapeutics Director Awarded $115K Worth of Stock Options – BioXcel Therapeutics (NASDAQ:BTAI) Benzinga
  5. BioXcel Therapeutics Announces Positive Topline Results From TRANQUILITY II Phase 3 Trial of BXCL501 for Acute Treatment of Alzheimer’s Disease-Related Agitation Yahoo Finance
  6. View Full Coverage on Google News

Read original article here

Leave a Comment